US FDA grants priority review for Millenium's MM drug Velcade
Monday, February 04, 2008 12:00 IST Cambridge, Massachusetts
The US Food and Drug Administration (FDA) has granted priority review to Millennium Pharmaceuticals' Velcade in patients with newly diagnosed multiple myeloma (MM)